4.7 Article

Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction

Journal

NEUROIMAGE
Volume 108, Issue -, Pages 450-459

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2014.11.055

Keywords

F-18-AV45-PET; Alzheimer's disease; Reference region; Partial volume effect correction

Funding

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  3. National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering
  4. Canadian Institutes of Health Research
  5. Alzheimer's Association
  6. Alzheimer's Drug Discovery Foundation
  7. BioClinica, Inc.
  8. Biogen Idec Inc.
  9. Bristol-Myers Squibb Company
  10. Eisai Inc.
  11. Elan Pharmaceuticals, Inc.
  12. Eli Lilly and Company
  13. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  14. GE Healthcare
  15. Innogenetics, N.V.
  16. IXICO Ltd
  17. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  18. Johnson & Johnson Pharmaceutical Research & Development LLC.
  19. Medpace, Inc.
  20. Merck Co., Inc.
  21. Meso Scale Diagnostics, LLC.
  22. NeuroRx Research
  23. Novartis Pharmaceuticals Corporation
  24. Pfizer Inc.
  25. Piramal Imaging
  26. Servier
  27. Synarc Inc.
  28. Takeda Pharmaceutical Company

Ask authors/readers for more resources

Amyloid positron-emission-tomography (PET) offers an important research and diagnostic tool for investigating Alzheimer's disease (AD). The majority of amyloid PET studies have used the cerebellum as a reference region, and clinical studies have not accounted for atrophy-based partial volume effects (PVE). Longitudinal studies using cerebellum as reference tissue have revealed only small mean increases and high inter-subject variability in amyloid binding. We aimed to test the effects of different reference regions and PVE-correction (PVEC) on the discriminatory power and longitudinal performance of amyloid PET. We analyzed [F-18]-AV45 PET and T1-weighted MRI data of 962 subjects at baseline and two-year follow-up data of 258 subjects. Cortical composite volume-of-interest (VOI) values (COMP) for tracer uptake were generated using either full brain atlas VOIs, gray matter segmented VOIs or gray matter segmented VOIs after VOI-based PVEC. Standard-uptake-value ratios (SUVR) were calculated by scaling the COMP values to uptake in cerebellum (SUVRCBL), brainstem (SUVRBST) or white matter (SUVRWM). Mean SUV, SUVR, and changes after PVEC were compared at baseline between diagnostic groups of healthy controls (HC; N=316), mild cognitive impairment (MCI; N=483) and AD (N=163). Receiver operating characteristics (ROC) were calculated for the discriminations between HC, MCI and AD, and expressed as area under the curve (AUC). Finally, the longitudinal [F-18]AV45- PET data were used to analyze the impact of quantitation procedures on apparent changes in amyloid load over time. Reference region SUV was most constant between diagnosis groups for the white matter. PVEC led to decreases of COMP-SUV in HC (-18%) and MCI (-10%), but increases in AD (+7%). Highest AUCs were found when using PVEC with white matter scaling for the contrast between HC/AD (0.907) or with brainstem scaling for the contrast between HC/MCI (0.658). Longitudinal increases were greatest in all diagnosis groups with application of PVEC, and inter-subject variability was lowest for the white matter reference. Thus, discriminatory power of [F-18]-AV45-PET was improved by use of a VOI-based PVEC and white matter or brainstem rather than cerebellum reference region. Detection of longitudinal amyloid increases was optimized with PVEC and white matter reference tissue. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available